Clinical Trials Browser

Enrolling by invitation × Leukemia, Myeloid, Acute × 1 year × Clear all

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Prostatic Neoplasms, Castration-Resistant

NCT00923442 2026-04-27

Biology Studies of Hematologic Cancers

Enrolling by invitation

550 enrolled

LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07537257 2026-04-17

VEN+IDAC vs IDAC in AML

Phase 2/3 Enrolling by invitation

232 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT07474051 2026-03-16

PERSIST

Enrolling by invitation

178 enrolled

GenitourinaryLymphoidOther hematologic neoplasm

Prostatic Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Hematologic Neoplasms

NCT05332054 2026-03-12

LTFS

Enrolling by invitation

150 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Hematologic Neoplasms

NCT04093570 2025-10-31

A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)

Phase 2 Enrolling by invitation

332 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT07014462 2025-10-06

DLIT-AML

Phase 1 Enrolling by invitation

20 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Clinical Trials

A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

Biology Studies of Hematologic Cancers

VEN+IDAC vs IDAC in AML

PERSIST

LTFS

A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)

DLIT-AML